The story of Viagra and the pharmaceutical industry presents a challenging picture for potential investors. Initially, copyright's blockbuster drug revolutionized the treatment of erectile dysfunction, creating significant profits and shaping the contemporary pharmaceutical landscape. However, intellectual property expiration and the appearance of